MBX Biosciences Company
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Headquarters:
Carmel, Indiana, United States
Total Funding:
$59.9M
Founded Date:
2019
Investors Number:
6
Estimated Revenue:
$1M to $10M
Investor Type:
For Profit
Technology:
Others
Employee Number:
1-10
Industry:
PharmTech
Last Funding Type:
Series A
Funding Status:
Early Stage Venture